Knockdown of Sox2 Inhibits OS Cells Invasion and Migration via Modulating Wnt/β-Catenin Signaling Pathway
Osteosarcoma (OS) was a prevalent malignant bone tumor which threatens people’s health worldwide. Wnt/β catenin signaling pathway had been proved significant in various cancers, indicating its possible function in OS as well. Sox2, a crucial member among SOX family could regulate cells biologically. How Sox2 modulated Wnt/β catenin signaling pathway in OS remained to be discussed. The study aimed to investigate the effects of Sox2 on the invasion and migration of OS cells and the related molecular mechanisms. Twenty-four human OS and adjacent tissue samples were involved in this study. Human OS cell lines MG63 and HOS were selected for further investigation. The liposome carrier si-Sox2 which could interfere with the expression of Sox2 gene was built to transfect MG63 and HOS cells). QRT-PCR assay and western blot were utilized to analyze the expression of mRNA and proteins of Sox2. Transwell assay and wound healing assay were conducted to test the invasion and migration level of cells. The expression of GSK3, β-catenin, cyclin D1 and c-myc proteins were detected by western blot assay after transfection with si-Sox2. Compared with normal tissues and cells, the expression of Sox2 in OS tissues and cells was significantly higher. The mRNA and protein levels of Sox2 significantly decreased after transfection with si-Sox2. The invasion and migration of OS cells were down-regulated significantly through the inhibition of Sox2 by inactivating Wnt/β-catenin signaling pathway related proteins. Knockdown of Sox2 could inhibit invasion and migration of OS cells via modulating Wnt/β-catenin signaling pathway.
KeywordsOsteosarcoma Sox2 Wnt/β-catenin
Compliance with Ethical Standards
Conflict of Interest
No conflict of interest exits in the submission of this manuscript and this manuscript has been approved by all authors for publication.
- 5.Zhang RX, Li Y, Tian DD, Liu Y, Nian W, Zou X, Chen QZ, Zhou LY, Deng ZL, He BC (2016) Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/beta-catenin signaling in human osteosarcoma cells. Int J Oncol 49(5):1973–1982. https://doi.org/10.3892/ijo.2016.3701 CrossRefGoogle Scholar
- 6.Nataraj V, Batra A, Rastogi S, Khan SA, Sharma MC, Vishnubhatla S, Bakhshi S (2015) Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: a single-center experience of 237 patients. J Surg Oncol 112(6):662–668. https://doi.org/10.1002/jso.24045 CrossRefGoogle Scholar
- 8.Ebb D, Meyers P, Grier H, Bernstein M, Gorlick R, Lipshultz SE, Krailo M, Devidas M, Barkauskas DA, Siegal GP, Ferguson WS, Letson GD, Marcus K, Goorin A, Beardsley P, Marina N (2012) Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. J Clin Oncol Off J Am Soc Clin Oncol 30(20):2545–2551. https://doi.org/10.1200/JCO.2011.37.4546 CrossRefGoogle Scholar
- 9.Chou AJ, Kleinerman ES, Krailo MD, Chen Z, Betcher DL, Healey JH, Conrad EU 3rd, Nieder ML, Weiner MA, Wells RJ, Womer RB, Meyers PA, Children's Oncology G (2009) Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. Cancer 115(22):5339–5348. https://doi.org/10.1002/cncr.24566 CrossRefPubMedCentralGoogle Scholar
- 10.Endicott AA, Morimoto LM, Kline CN, Wiemels JL, Metayer C, Walsh KM (2017) Perinatal factors associated with clinical presentation of osteosarcoma in children and adolescents. Pediatr Blood Cancer 64(6). https://doi.org/10.1002/pbc.26349
- 13.Zhan P, Zhang B, Xi GM, Wu Y, Liu HB, Liu YF, WJ X, Zhu QQ, Cai F, Zhou ZJ, Miu YY, Wang XX, Jin JJ, Li Q, Qian LP, Lv TF, Song Y (2017) PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/beta-catenin signaling pathway. Mol Cancer 16(1):108. https://doi.org/10.1186/s12943-017-0682-z CrossRefPubMedCentralGoogle Scholar
- 14.Peng L, Liu Z, Xiao J, Tu Y, Wan Z, Xiong H, Li Y, Xiao W (2017) MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/beta-catenin signaling pathway. Oncol Rep 38(1):301–308. https://doi.org/10.3892/or.2017.5705 CrossRefGoogle Scholar
- 15.Zhu B, Cheng D, Li S, Zhou S, Yang Q (2016) High expression of XRCC6 promotes human osteosarcoma cell proliferation through the beta-catenin/Wnt signaling pathway and is associated with poor prognosis. Int J Mol Sci 17(7). https://doi.org/10.3390/ijms17071188
- 22.Ten Kate FJC, van Olphen SH, Bruno MJ, Wijnhoven BPL, van Lanschot JJB, Looijenga LHJ, Fitzgerald RC, Biermann K (2017) Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma. Br J Surg 104(10):1327–1337. https://doi.org/10.1002/bjs.10553 CrossRefPubMedCentralGoogle Scholar
- 30.Martins-Neves SR, Corver WE, Paiva-Oliveira DI, van den Akker BE, Briaire-de-Bruijn IH, Bovee JV, Gomes CM, Cleton-Jansen AM (2016) Osteosarcoma stem cells have active Wnt/beta-catenin and Overexpress SOX2 and KLF4. J Cell Physiol 231(4):876–886. https://doi.org/10.1002/jcp.25179 CrossRefGoogle Scholar